Tag Archives: NASDAQ:LOXO

William Blair Downgrades Loxo Oncology (LOXO) to Hold

In a report released today, Raju Prasad from William Blair downgraded Loxo Oncology (LOXO – Research Report) to Hold. The company’s shares opened today at $233.31, close to its 52-week high of $233.90. According to TipRanks.com, Prasad is a 4-star

William Blair Maintains a Buy Rating on Loxo Oncology (LOXO)

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Loxo Oncology (LOXO – Research Report). The company’s shares closed on Friday at $139.87. According to TipRanks.com, Prasad is a 1-star analyst with an average

JMP Securities Reiterates a Buy Rating on Loxo Oncology (LOXO)

In a report issued on November 27, Konstantinos Aprilakis from JMP Securities reiterated a Buy rating on Loxo Oncology (LOXO – Research Report), with a price target of $215. The company’s shares closed yesterday at $144.54. Aprilakis noted: “We view

Oppenheimer Remains a Buy on Loxo Oncology (LOXO)

Oppenheimer analyst Leah R. Cann maintained a Buy rating on Loxo Oncology (LOXO – Research Report) today and set a price target of $185. The company’s shares opened today at $173.73. Cann wrote: “Loxo’s lower than estimated 3Q18 loss resulted

Analysts Offer Insights on Healthcare Companies: Loxo Oncology (NASDAQ: LOXO) and Amgen Inc (NASDAQ: AMGN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Loxo Oncology (NASDAQ:LOXO) and Amgen Inc (NASDAQ:AMGN) with bullish sentiments. Loxo Oncology (LOXO) Citigroup analyst Yigal Nochomovitz maintained a Buy rating on

Loxo Oncology (LOXO) Gets a Buy Rating from William Blair

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Loxo Oncology (NASDAQ: LOXO). The company’s shares closed on Friday at $159.60. According to TipRanks.com, Prasad is a 3-star analyst with an average return of